While ribociclib 10 mg/kg daily resulted in partial inhibition (maximally 46%) of Rb phosphorylation in tumor tissue over a 24-hour period after the last dose, >90% inhibition of Rb phosphorylation was observed for most time points at the 75 and 150 mg/kg doses. The gene discussed is RB1; the disease is neoplasm.